The need for a point of care testing: An evidence-based appraisal

Scandinavian Journal of Clinical and Laboratory Investigation, Supplement

Volumn 59, Issue 230, 1999, Pages 67-73

  Collinson, Paul O ^a,b  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b MAYDAY UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; CREATINE KINASE MB; MYOGLOBIN; TROPONIN I; TROPONIN T; BIOLOGICAL MARKER; ISOENZYME;

ACUTE HEART INFARCTION; CONFERENCE PAPER; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ELECTROCARDIOGRAPHY; EVIDENCE BASED MEDICINE; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; ST SEGMENT ELEVATION; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ECONOMICS; HEART INFARCTION; HOSPITAL COST; HOSPITAL INFORMATION SYSTEM; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; STANDARD; STATISTICS;

ANGINA;

BIOLOGICAL MARKERS; CREATINE KINASE; EVIDENCE-BASED MEDICINE; FEMALE; HOSPITAL COSTS; HUMANS; ISOENZYMES; LENGTH OF STAY; MALE; MYOCARDIAL INFARCTION; MYOGLOBIN; POINT-OF-CARE SYSTEMS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TROPONIN I; TROPONIN T;

EID: 0033037119     PISSN: 0085591X     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365519909168329     Document Type: Conference Paper

References (53)

1. AIMS (Anistreplase Intervention Mortality study) Trial study group. Effects of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo controlled clinical trial. Lancet 1988; i: 545-549
2. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet. 2(8607):349-60, 1988 Aug 13.
3. Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Gruppo Italiano per lo Studio della Streptochi-nasi nell'Infarto Miocardico (GISSI. Lancet; 1987. ii:871-4.
4. Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction. Lancet. 1993; 342:759-66.
5. Wilcox RG. von der Lippe G. Olsson CG. Jensen G. Skene AM. Hampton JR. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET) Lancet.1988; ii: 525-30
6. Wilcox RG. von der Lippe G. Olsson CG. Jensen G. Skene AM. Hampton JR. Effects of alteplase in acute myocardial infarction: 6-month results from the ASSET study. Anglo-Scandinavian Study of Early Thrombolysis. Lancet. 1990; 335:1175-8
7. Fibrinolytic Therapy Trialists Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343:311-22
8. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. Circulation. 1994; 89:1545-56
9. Lee TH, Weisberg MC, Brand DA, Rouan GW, Goldman L. Candidates for thrombolysis among emergency room patients with acute chest pain. Ann. Internal. Medicine. 1989; 110:957-962.
10. Adams JN, Jamieson M, Trent RJ, Rawles J, Jennings KP. The risks of thrombolysis in patients without acute myocardial infarction. International Journal of Cardiology 1995; 51: 177-81
11. Stubbs P, Collinson P, Moseley D, Greenwood T, Noble M. Prognostic significance of admission troponin T concentrations in patients with myocardial infarction. Circulation 1996; 94:1291-7
12. Ohman ME, Armstrong PW, Christenson RH, Granger CB, Katus HA, Hamm CW et al. Cardiac troponin T levels for risk stratification in acute myocardial ischaemia. NEJM 1996; 335:1333-41
13. Antman EM, Tanasijeevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP et al. Cardiac specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. NEJM 1996;335:1342-9
14. McQueen M, Holder D. El-Maraghi N. Assessment of the accuracy of serial electrocardiography in the diagnosis of acute myocardial infarction. Am Heart J. 1983; 105: 258-61
15. Zarling EJ, Sexton H, Milnor P. Failure to diagnose acute myocardial infarction. JAMA 1983; 250: 1177-81
16. Slater DK, Hlatky MA, Mark DB, Harrel FE, Pryor DB, Califf RM. Outcome in suspected acute myocardial infarction with normal or minimally abnormal admission electrocardiographic findings. Am. J. Cardiol. 1987; 60: 766-770
17. Brush JE, Brand DA, Acampora A, Chalmer B, Wackers FJ. Use of the admission electrocardiogram to predict in-hospital complications of acute myocardial infarction. NEJM 1985; 312: 1137-1141
18. Yusuf S, Pearson M, Sterry H, Parish S, Ramsdale D, Rossi P, Sleight P. The entry ECG in the early diagnosis and prognostic stratification of patients with suspected acute myocardial infarction. European Heart Journal. 1984; 5: 690-646
19. Collinson PO, Ramhamadamy EM, Rosalki SB, Joffe J, Evans DH, Fink RS, Greenwood TW, Baird IM. Diagnosis of acute myocardial infarction from sequential enzyme measurements obtained within 12 hours of admission to hospital. J. Clin. Pathol. 1989; 42 : 1126-31.
20. Collinson PO, Stubbs PJ. 4 hour "rule-in" diagnosis of acute myocardial infarction for early risk stratification by creatine kinase increment (CK change). Ann Clin Biochem 1996; 33: 308-13
21. Mair J. Smidt J. Lechleitner P. Dienstl F. Puschendorf B. Rapid accurate diagnosis of acute myocardial infarction in patients with non-traumatic chest pain within 1 h of admission. Coronary Artery Disease. 1995; 6:539-45
22. Lindahl B. Venge P. Wallentin L. Early diagnosis and exclusion of acute myocardial infarction using biochemical monitoring. The BIOMACS Study Group. Biochemical Markers of Acute Coronary Syndromes. Coronary Artery Disease. 1995; 6:321-8
23. Young GP. Gibier WB. Hedges JR. Hoekstra JW. Slovis C. Aghababian R. Smith M. Rubison M. Ellis J. Serial creatine kinase-MB results are a sensitive indicator of acute myocardial infarction in chest pain patients with non diagnostic electrocardiograms: the second Emergency Medicine Cardiac Research Group Study. Academic Emergency Medicine. 1997; 4:869-77
24. Hamm CW. Goldmann BU. Heeschen C. Kreymann G. Berger J. Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I . New England Journal of Medicine. 1997; 337:1648-53
25. Stubbs P, Collinson P, Moseley D, Greenwood T, Noble M. Prospective study of the role of cardiac troponin T in patients admitted with unstable angina. BMJ 1996; 313:262-4
26. Lindahl B, Venge P, Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation 1996; 93:1651-7
27. Collinson PO. T or I or MB (or none?) European Heart Journal 1998; 19 (Suppl N): N16-24.
28. Lindahl B. Venge P. Wallentin L. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. Journal of the American College of Cardiology.29: 43-8
29. White H Stewart JT. French JK. Theroux P. Ramanathan K. Solymoss BC. Johnson R. White HD. Early non-invasive identification of failed reperfusion after intravenous thrombolytic therapy in acute myocardial infarction. Journal of the American College of Cardiology. 1998; 31:1499-505
30. Hamm CW, Heeschen C, Goldman BU et al. Value of troponins in predicting therapeutic efficacy of abciximab in patients with unstable angina. JACC 198; 31: 185A (suppl A)
31. Collinson PO, Ramhamadamy EM, Stubbs PJ, Rosalki SB, Garrat HM, Mosely D, Evans DH, Fink FS, Baird IM, Greenwood TW. Rapid enzyme diagnosis of patients with acute chest pain reduces patient stay in the coronary care unit. Ann Clin Biochem. 1993; 30: 17-22.
32. Gibler WB. Runyon JP. Levy RC. Sayre MR. Kacich R. Hattemer CR. Hamilton C. Gerlach JW. Walsh RA. A rapid diagnostic and treatment center for patients with chest pain in the emergency department. Annals of Emergency Medicine.1995; 25:1-8, 1995 Jan.
33. Hedges JR. Gibier WB. Young GP. Hoekstra JW. Slovis C. Aghababian R. Smith M. Rubison M. Multicenter study of creatine kinase-MB use: effect on chest pain clinical decision making. Academic Emergency Medicine. 1996; 3:7-15
34. Wu AH. Clive JM. Impact of CK-MB testing policies on hospital length of stay and laboratory costs for patients with myocardial infarction or chest pain. Clinical Chemistry. 1997; 43:326-32
35. Apple FS. Preese LM. Riley L. Gerken KL. Van Lente F. Financial impact of a rapid CK-MB-specific immunoassay on the diagnosis of myocardial infarction. Archives of Pathology & Laboratory Medicine. 1990; 114:1017-20
36. Ramhamadamy E, Collinson PO, Evans DH, Fink RS, Baird IM. Evaluation of the AMES seralyser for measurement of creatine kinase in the coronary care unit. Clin Chem 1988; 34 : 1914
37. Schouten Y. de Winter RJ. Gorgels JP. Koster RW. Adams R. Sanders GT. Clinical evaluation of the cardiac STATus, a rapid immunochromatographic assay for simultaneous detection of elevated concentrations of CK-MB and myoglobin in whole blood. Clinical Chemistry & Laboratory Medicine. 1998; 36:469-73
38. Brogan GX Jr. Bock JL. McCuskey CF. Hollander JE. Thode H Jr. Gawad Y. Jackowski G. Evaluation of cardiac STATus CK-MB/myoglobin device for rapidly ruling out acute myocardial infarction. Clinics in Laboratory Medicine. 1997; 17:655-68
39. Collinson PO. Thomas S. Siu L. Vasudeva P. Stubbs PJ. Canepa-Anson R. Rapid troponin T measurement in whole blood for detection of myocardial damage. Annals of Clinical Biochemistry. 1995; 32:454-8, 1995.
40. Collinson PO. Gerhardt W. Katus HA. Muller-Bardorff M. Braun S. Schricke U. Vogt W. Nagel D. Zander M. Leinberger R. Mangold D. Zerback R. Multicentre evaluation of an immunological rapid test for the detection of troponin T in whole blood samples. European Journal of Clinical Chemistry & Clinical Biochemistry. 1996; 34:591-8.
41. Muller-Bardorff M, Freitag H, Scheffold T, Remppis, Kubler W, Kattus HA. Development and characterization of a rapid assay for bedside determinations of cardiac troponin T. Circulation. 1995; 92:2869-75
42. Hirschl MM. Lechleitner P. Friedrich G. Sint G. Sterz F. Binder M. Dienstl F. Laggner AN. Usefulness of a new rapid bedside troponin T assay in patients with chest pain. Resuscitation. 1996; 32:193-8.
43. Gerhardt W, Ljungdahl L, Collinson PO, Lovis C, Mach F, Sylven C, Rasmanis G, Leinberger R, Zerback R, Muller-Bardorff M, Katus HA. An improved rapid troponin T test with a decreased detection limit: a multicentre study of the analytical and clinical performance in suspected myocardial damage. Scandinavian Journal of Clinical & Laboratory Investigation. 1997; 57:549-57
44. Muller-Bardorff, Waldenhofer U, Sylven C, Collinson PO, Gerhardt W, Hafner G, Zerback R, M, Katus HA.Multicentre evaluation of a new point of care system for the quantiative determination of troponin T and myoglobin. Clin Chem 1998; 44: (Suppl) A129.
45. Anonymous. Evaluation of a bedside whole-blood rapid troponin T assay in the emergency department. Rapid Evaluation by Assay of Cardiac Troponin T (REACTT) Investigators Study Group. Academic Emergency Medicine. 1997; 4:1018-24, 1997
46. Heeschen C. Goldmann BU. Moeller RH. Hamm CW. Analytical performance and clinical application of a new rapid bedside assay for the detection of serum cardiac troponin I. Clinical Chemistry. 1998; 44:1925-30.
47. Panteghini M. Cuccia C. Pagani F. Turla C. Comparison of the diagnostic performance of two rapid bedside biochemical assays in the early detection of acute myocardial infarction. Clinical Cardiology. 1998; 21:394-8.
48. Sylven C. Lindahl S. Hellkvist K. Nyquist O. Rasmanis G. Excellent reliability of nurse-based bedside diagnosis of acute myocardial infarction by rapid dry-strip creatine kinase MB, myoglobin, and troponin T. American Heart Journal. 1998; 135:677-83.
49. Luscher MS. Ravkilde J. Thygesen K. Clinical application of two novel rapid bedside tests for the detection of cardiac troponin T and creatine kinase-MB mass/myoglobin in whole blood in acute myocardial infarction. Cardiology. 1998; 89:222-8.
50. Hamm CW. Goldmann BU. Heeschen C. Kreymann G. Berger J. Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I . New England Journal of Medicine. 1997; 337:1648-53
51. Hoekstra JW, Gibier WB, Levy RC, Sayre M, Naber W, Chandra A et al. Emergency department diagnosis of acute myocardial infarction and ischaemia: A cost analysis of two diagnostic protocols. Acad Emerg Med 1994; 1: 103-10.
52. Gomez MA, Andesron JL, Karagounis LA, Muhlestein JB, Mooers FB. An emergency department based protocol for rapidly ruling out myocardial ischaemia reduces hospital time and expense: results of a randomised study (ROMIO). Journal of the American College of Cardiology; 1996; 28:25-33
53. Collinson PO. Cost economics of new cardiac markers - CK-MB and cardiac troponins. In Myocardial damage: Early detection by novel biochemical markers. Kaski CJ, Holt D (eds). Kluwer Academic Publishers B.V. The Netherlands. 1998.